Abstract: A pharmaceutical composition for the treatment, prevention or diagnosis of a tumoral pathology comprising an active agent which stabilizes an actin network of a cellular cytoskeleton.
Type:
Application
Filed:
December 18, 2003
Publication date:
September 30, 2004
Applicants:
Bioalliance Pharma, a corporation of France, Ecole Normale Superieure de Cachan, a corporation of France, Institut Gustave Roussy - IGR, a corporation of France, Centre National de la Recherche Scientifique - CNRS, a corporation of France
Inventors:
Christian Auclair, Valerie Amsellem, Martial Hervy, Frederic Subra
Abstract: A molecule binding to a target including an EP motif having the following sequence: (X-(EP)n-Y-(EP)m-Z)p wherein X, Y and Z may be identical or different and include a sequence of 0 to 10 amino acids, identical or different, n and m are integers between 0 to 20, preferably between 3 to 10, with at least one of n or m being different from 0, and p is an integer between 1 and 10.
Type:
Application
Filed:
March 18, 2004
Publication date:
September 2, 2004
Applicants:
Institut Gustave Roussy - IGR, a corporation of France, Universite Paris-Sud, a corporation of France